ALR Technologies Releases Webinar Recording With America's Health Insurance Plans; Clinical Trial Data Found Internet-Based Glucose Monitoring and Continuous Glucose Monitoring to Be Comparable
(firmenpresse) - RICHMOND, VA -- (Marketwired) -- 07/22/13 -- ALR Technologies Inc. (OTCBB: ALRT) released onto its website a recording of a Webinar conducted by Dr. Kent Stoneking, ALRT's Director of Diabetes Care Facilitation, discussing the results of a recent clinical trial comparing an Internet-based Glucose Monitoring System (IBGMS) with a Continuous Glucose Monitoring System (CGMS). The Webinar was presented to medical directors and other clinical staff from health plans that are members of America's Health Insurance Plans (AHIP). Despite the greater cost of and invasive nature of CGMS, the trial results found that the clinical results of the two systems were comparable.
Providers should note that some patients might require the more intensive monitoring provided by the CGM systems. Therefore these trial results are not meant to demonstrate that the two technologies are interchangeable, only that IBGMS may be a cost effective option for many patients who do not require CGM.
The Webinar is linked here:
ALR Technologies is a medical device company providing remote monitoring and care facilitation for patients with chronic diseases. ALRT has developed the FDA-cleared and HIPAA compliant Health-e-Connect System that collects data from blood glucose meters and uploads to a secure website. Trained Facilitators use the System to effect efficiency of care among patients, clinicians and caregivers to improve outcomes and assist health plans to optimize their HEDIS goals. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data.
This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate", "expect", "anticipate", "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities Exchange.
Contact:
Bill Smith
203.762.1073
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 22.07.2013 - 12:18 Uhr
Sprache: Deutsch
News-ID 280367
Anzahl Zeichen: 0
contact information:
Town:
RICHMOND, VA
Kategorie:
Alternative
Diese Pressemitteilung wurde bisher 248 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ALR Technologies Releases Webinar Recording With America's Health Insurance Plans; Clinical Trial Data Found Internet-Based Glucose Monitoring and Continuous Glucose Monitoring to Be Comparable"
steht unter der journalistisch-redaktionellen Verantwortung von
ALR Technologies (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
